Author

Sandra Menoyo

Institut d'Investigació Biomédica de BellvitgeORCID 0000-0002-7913-492XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Antonio GentilellaiD· 1 shared Berta Forcada· 1 shared Cristina SantosiD· 1 shared Francisco D. Morón-DuraniD· 1 shared Pau Bosch-i-CrespoiD· 1 shared Ramón SalazariD· 1 shared Zoi Mastora· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Antonio GentilellaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintAug 27, 2026

Pharmacologic decoupling of IRBC activation from anabolic collapse redefines ribosome biogenesis inhibition as a selective tumor suppressive strategy

Sandra Menoyo, Berta Forcada, Zoi Mastora…·Antonio Gentilella

This study shows that inhibiting ribosome biogenesis can selectively activate the IRBC checkpoint in TP53-proficient cells, offering a new therapeutic strategy for cancer.

DOI 10.64898/2026.08.24.744089

humanexperimental assay

𝕏 PostBluesky